Abacavir/Dolutegravir/Lamivudine (By mouth)
a-BAK-a-vir, doe-loo-TEG-ra-vir, la-MIV-ue-deen
Antiretroviral Agent (About this – PubMed Health)
Uses of This Medicine
Abacavir, dolutegravir, and lamivudine combination is used for the treatment of the infection caused by human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Abacavir, dolutegravir, and lamivudine combination will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems that usually result from AIDS or HIV disease. Abacavir, dolutegravir, and lamivudine combination will not keep you from spreading HIV to other people. People who receive this medicine may continue to have some of the problems usually related to AIDS or HIV disease.
This medicine is available only with your doctor’s prescription.
Other uses (PubMed Health)
How To Use
Your doctor will tell you how much medicine to use. Do not use more than directed.
This medicine should come with a Medication Guide. Ask your pharmacist for a copy if you do not have one.
Missed dose: Take a dose as soon as you remember. If it is less than 4 hours until your next dose, skip the missed dose and take your next dose at the regular time. Do not take extra medicine to make up for a missed dose.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light.
Drugs and Foods to Avoid
Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.
Do not use dofetilide while you are using this medicine.
Some medicines and foods can affect how abacavir/dolutegravir/lamivudine works. Tell your doctor if you are using any of the following:Carbamazepine, efavirenz, etravirine, fosamprenavir, interferon alfa, metformin, nevirapine, oxcarbazepine, phenobarbital, phenytoin, ribavirin, rifampin, ritonavir, St John’s wort, tipranavir
Supplements that contain calcium or iron (such as multivitamins) may be taken with this medicine if you take them with food.
When Not To Use
This medicine is not right for everyone. Do not use it if you had an allergic reaction to abacavir, dolutegravir, or lamivudine.
Do not breastfeed. You can spread HIV or AIDS to your baby through your breast milk.
This medicine may cause the following problems:Lactic acidosis (too much acid in the blood) Liver problems Increased risk of heart attack
This medicine may cause serious allergic reactions. Ask your pharmacist for a warning card listing the symptoms of an allergic reaction. Carry the card with you at all times.
Your immune system may get stronger when you start taking HIV medicines. Sometimes the immune system will start to fight infections that were hidden in your body, such as pneumonia or tuberculosis. Tell your doctor right away if you notice any changes in your health.
This medicine will not keep you from giving HIV to others. Always practice safe sex, even if your partner also has HIV. Do not share needles or other items that may have blood or body fluids on them.
Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Keep all medicine out of the reach of children. Never share your medicine with anyone.
Possible side effects
Summary More details
Call your doctor right away if you notice any of these side effects:
Fast breathing, trouble breathing, nausea and vomiting, lightheadedness, severe weakness, tiredness, or confusion
Fever, rash, nausea, vomiting, severe tiredness, shortness of breath, pain or swelling around your eye
If you notice these less serious side effects, talk with your doctor:
If you notice other side effects that you think are caused by this medicine, tell your doctor.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
More side effects of this drug
Brand names include
There may be other brand names for this medicine.